manilatimes10 分钟
Qu Biologics' Site Specific Immunomodulator Enables CAR T-cell Cancer Efficacy in Solid Tumor
Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel ...